SCHEMBL10868170

SCHEMBL10868170

COc1ccc(-n2c(C)nnc2CO)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OXTR P30559 2/20 0.52
▸ TLR8 Q9NR97 1/20 0.50
▸ AVPR2 P30518 1/20 0.50
▸ AVPR1A P37288 1/20 0.50
▸ P2RX7 Q99572 1/20 0.48
▸ GAA P10253 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ TNKS2 Q9H2K2 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ TNKS O95271 1/20 0.44
▸ AXIN2 Q9Y2T1 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 2/20 0.42
▸ THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11285464 0.80 AVPR1A (0.51) OXTRAVPR1AGAAALDH1A1HTT
SCHEMBL17982136 0.75 ALDH1A1 (0.54) GAANPC1ALDH1A1HTTL3MBTL1
SCHEMBL2551450 0.75 OXTR (0.56) OXTRAVPR2AVPR1AGAAPOLB
SCHEMBL30366678 0.73 CYP3A4 (0.63) OXTRGAAPOLBCYP3A4CYP2C9
SCHEMBL10515467 0.73 NPC1 (0.57) TLR8P2RX7GAACYP3A4CYP2C9
SCHEMBL8879929 0.71 ALDH1A1 (0.61) P2RX7GAACYP3A4ALDH1A1HTT
Hydrochloric Acid SCHEMBL11375354 0.71 TLR8 (0.57) OXTRTLR8AVPR2AVPR1AGAA
SCHEMBL9422988 0.70 OXTR (0.58) OXTRAVPR2AVPR1AALDH1A1HTT
SCHEMBL28496152 0.69 TLR8 (0.68) TLR8P2RX7GAANPC1ALDH1A1
SCHEMBL930548 0.69 OXTR (0.74) OXTRAVPR2AVPR1ATNKS2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0176444-A1 Process for the preparation of derivatives of 4H-1,2,4-triazole, triazoles so obtained, their use as medicaments, and pharmaceutical compositons containing them ROUSSEL-UCLAF (FR) 1986-04-02 — — EP disclosed
Send feedback